Franz-Ulrich Hartl receives Lasker Award – Award for Research on Protein Folding
Together with Arthur L. Horwich (Yale University, USA), Franz-Ulrich Hartl, director at the Max Planck Institute of Biochemistry, will be awarded the 2011 Albert Lasker Basic Medical Research Award for his research on protein folding. The prize comes with a shared $250,000 honorarium and will be awarded by the Lasker Foundation on September 23, 2011 in New York, USA.
Hartl and Horwich discovered that not all proteins can fold inside cells by themselves. They determined that a protein called Chaperonin acts as a cage-like folding “machine” that provides a safe place for proteins to fold, away from outside interference.
“By unraveling the mysterious workings of these amazing machines, the researchers gave the medical world a key understanding of how proteins reach their biological potential”, says Maria C. Freire, President of the Lasker Foundation. Because faulty proteins also play a role in neurodegenerative diseases such as Alzheimer’s or Parkinson, Hartl’s results could contribute significantly to developing new drugs for the treatment of these diseases.
Contact:
Prof. Dr. F.-Ulrich Hartl
Cellular Biochemistry
Max Planck Institute of Biochemistry
Am Klopferspitz 18
82152 Martinsried
Germany
E-Mail: uhartl@biochem.mpg.de
Anja Konschak
Public Relations
Max Planck Institute of Biochemistry
Am Klopferspitz 18
82152 Martinsried
Germany
Tel. ++49 89 8578-2824
E-Mail: konschak@biochem.mpg.de
Media Contact
More Information:
http://www.biochem.mpg.deAll latest news from the category: Awards Funding
Newest articles
Largest magnetic anisotropy of a molecule measured at BESSY II
At the Berlin synchrotron radiation source BESSY II, the largest magnetic anisotropy of a single molecule ever measured experimentally has been determined. The larger this anisotropy is, the better a…
Breaking boundaries: Researchers isolate quantum coherence in classical light systems
LSU quantum researchers uncover hidden quantum behaviors within classical light, which could make quantum technologies robust. Understanding the boundary between classical and quantum physics has long been a central question…
MRI-first strategy for prostate cancer detection proves to be safe
Active monitoring is a sufficiently safe option when prostate MRI findings are negative. There are several strategies for the early detection of prostate cancer. The first step is often a…